Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein

Viral Immunology

Volumn 20, Issue 1, 2007, Pages 56-65

  Srivastava, Ruchi ^a   Aggarwal, Rakesh ^a   Jameel, Shahid ^b   Puri, Pankaj ^c   Gupta, Vijay K ^c   Ramesh, V S ^d   Bhatia, Shobna ^d   Naik, Sita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^c Command Hospital ^*  (India)

^d BYL Nair Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CD3 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; IONOMYCIN; OPEN READING FRAME 2 PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HEPATITIS E VIRUS; HUMAN; HUMAN TISSUE; MALE; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

ACUTE DISEASE; CYTOKINES; FEMALE; HEPATITIS E; HUMANS; IONOMYCIN; MALE; RNA, MESSENGER; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; VIRAL PROTEINS;

HEPATITIS E VIRUS;

EID: 34247262133     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.0053     Document Type: Article

References (32)

1. Aggarwal R, and Krawczynski K: Hepatitis E: An overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol 2000;15:9-20.
2. Aggarwal R, Shukla R, Jameel S, Agrawal S, Puri P, Gupta VK, Patil AP, and Naik S: T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. J Viral Hepat 2007 (in press) doi: 10.1111j.1365-2893.2006.00796.x.
3. Arora NK, Nanda SK, Gulati S, Ansari IH, Chawla YK, Gupta SD, and Panda SK: Acute viral hepatitis types E, A, and B singly and in combination in acute liver failure in children in north India. J Med Virol 1996;48:215-221.
4. Bradley DW, Krawczynski K, Cook EH Jr, McCaustland KA, Humphrey CD, Spelbring JE, Myint H, and Maynard JE: Enterically transmitted non-A, non-B hepatitis: Serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27- to 34-nm viruslike particles. Proc Natl Acad Sci USA 1987;84:6277-6281.
5. Doherty DG, and O'Farrelley C: Lymphoid repertoires in healthy liver. In: Liver Immunology (Gershwin ME, Vierling JM, and Manns MN, eds.). Hanley & Belfus, Philadelphia, 2003, pp. 31-46.
6. Exley MA, and Koziel MJ: To be or not to be NKT: Natural killer T cells in the liver. Hepatology 2004;40:1033-1040.
7. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, and Purcell RH: Lack of protective immunity against reinfection with hepatitis C virus. Science 1992;258:135-140.
8. Guidotti LG, and Chisari FV: Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001;19:65-91.
9. Guidotti LG, and Chisari FV: Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol Mech Dis 2006;1:23-61.
10. Khuroo MS: Study of an epidemic of non-A, non-B hepatitis: Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980;68:818-823.
11. Khuroo MS, Teli RT, Skidmore S, Sofi MA, and Khuroo HI: Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981;70:252-255.
12. Khuroo MS, Kamili S, Dar MY, Moecklii R, and Jameel S: Hepatitis E and long-term antibody status. Lancet 1993;341:1355.
13. Knolle PA, Gerken G, Loser E, Dienes HP, Gantner F, Tiegs G, Meyer zum Buschenfelde KH, and Lohse AW: Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice. Hepatology 1996;24:824-829.
14. Krawczynski K, Aggarwal R, and Kamili S: Hepatitis E. Infect Dis Clin North Am 2000;14:669-687.
15. Murray K, Bruce SA, Hinnen A, Wingfield P, van Erd PM, de Reus A, and Schellekens H: Hepatitis B virus antigens made in microbial cells immunise against viral infection. EMBO J 1984;3:645-650.
16. Naik S, Aggarwal R, Naik SR, Dwivedi S, Talwar S, Tyagi SK, Duhan SD, and Coursaget P: Evidence for activation of cellular immune responses in patients with acute hepatitis E. Indian. J Gastroenterol 2002;21:149-152.
17. Naik SR, Aggarwal R, Salunke PN, and Mehrotra NN: A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 1992;70:597-604.
18. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, and Nagata S: Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-809.
19. Pal R, Aggarwal R, Naik SR, Das V, Das S, and Naik S: Immunological alterations in pregnant women with acute hepatitis E. J Gastroenterol Hepatol 2005;20:1094-1101.
20. Pringle CR: Virus taxonomy: San Diego 1998. Arch Virol 1998;143:1449-1459.
21. Rehermann B: Intrahepatic T cells. In: Liver Immunology (Gershwin ME, Vierling JM, and Manns MN, eds.). Hanley & Belfus, Philadelphia, 2003, pp. 47-58.
22. Schofield DJ, Glamann J, Emerson SU, and Purcell RH: Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J Virol 2000;74:5548-5555.
23. Sigal LJ, Crotty S, Andino R, and Rock KL: Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigens. Nature 1999;398:77-80.
24. Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, and Hayakawa Y: Activation of NK cell cytoxicity. Mol Immunol 2005;42:501-510.
25. Szomolanyi-Tsuda E, Brehm MA, and Welsh RM: Acquired immunity against viral infections. In: Immunology of Infectious Diseases (Kaufmann SHE, Sher A, and Ahmed R, eds.). ASM Press, Washington, D.C., 2002, pp. 247-265.
26. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, and Reyes GR: Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome. Virology 1991;185:120-131.
27. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, and Chisari FV: Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001;194:1395-1406.
28. Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, Govindarajan S, Purcell RH, and Chisari FV: Viral and immunological determinants of hepatitis C virus clearance, persistence and disease. Proc Natl Acad Sci USA 2002;99:15661-15668.
29. + T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003;77:68-76.
30. Vishwanathan R: Infectious hepatitis in Delhi (1955-56): A critical study: epidemiology. Indian J Med Res 1957;45(Suppl 1):1-29.
31. Zafrullah M, Ozdener MH, Panda SK, and Jameel S: The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J Virol 1997;71:9045-9053.
32. Zafrullah M, Khursheed Z, Yadav S, Sahgal D, Jameel S, and Ahmad F: Acidic pH enhances structure and structural stability of the capsid protein of hepatitis E virus. Biochem Biophys Res Commun 2004;313:67-73.